Tenet Healthcare Corp (NYSE:THC) has earned an average recommendation of “Hold” from the seventeen ratings firms that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $18.33.
Several equities research analysts have weighed in on THC shares. JPMorgan Chase & Co. cut shares of Tenet Healthcare from a “neutral” rating to an “underweight” rating and set a $15.00 price objective for the company. in a research report on Thursday, December 14th. ValuEngine cut shares of Tenet Healthcare from a “hold” rating to a “sell” rating in a research report on Sunday, December 31st. Citigroup upgraded shares of Tenet Healthcare from a “neutral” rating to a “buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research upgraded shares of Tenet Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, November 3rd. Finally, William Blair restated a “market perform” rating on shares of Tenet Healthcare in a research report on Tuesday, November 21st.
In other Tenet Healthcare news, Director George Fredrick Smitherman purchased 125,000 shares of the stock in a transaction dated Thursday, January 25th. The stock was bought at an average price of $38.50 per share, for a total transaction of $4,812,500.00. In the last quarter, insiders have sold 54,600 shares of company stock valued at $94,146. 3.10% of the stock is owned by corporate insiders.
Shares of Tenet Healthcare (NYSE:THC) opened at $19.50 on Tuesday. The company has a debt-to-equity ratio of 21.21, a current ratio of 1.28 and a quick ratio of 1.21. The firm has a market cap of $1,968.27, a PE ratio of -3.54, a price-to-earnings-growth ratio of 3.68 and a beta of 1.24. Tenet Healthcare has a 1 year low of $12.25 and a 1 year high of $22.72.
TRADEMARK VIOLATION NOTICE: “Tenet Healthcare Corp (THC) Receives Consensus Rating of “Hold” from Analysts” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://stocknewstimes.com/2018/02/20/tenet-healthcare-corp-thc-receives-consensus-rating-of-hold-from-analysts.html.
About Tenet Healthcare
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.